CAS: 922139-31-9 - Recilisib sodium

Formel: C₁₆H₁₃ClO₄S·Na

InChl: InChI=1S/C16H13ClO4S.Na/c17-15-7-3-13(4-8-15)11-22(20,21)10-9-12-1-5-14(6-2-12)16(18)19;/h1-10H,11H2,(H,18,19);/b10-9+;

InChI Key: InChIKey=NNNJPDWCCZUPQL-RRABGKBLSA-N

SMILES: [Na].O=C(O)C1=CC=C(C=C1)C=CS(=O)(=O)CC2=CC=C(Cl)C=C2

Synonyme:

• Ex-Rad
• Recilisib sodium
• ON 01210.Na
• Benzoic acid, 4-[(1E)-2-[[(4-chlorophenyl)methyl]sulfonyl]ethenyl]-, sodium salt (1:1)
• Sodium 4-[(1E)-2-[[(4-chlorophenyl)methyl]sulfonyl]ethenyl]benzoate (1:1)

Recilisib sodium

CAS: 922139-31-9

Recilisib (ON 01210.Na) is a radioprotective agent altering cancer cell cycles and preventing radiation-induced apoptosis.

• Formel: C₁₆H₁₃ClNaO₄S
• Farbe und Form: Solid
• Molekulargewicht: 359.78

Recilisib sodium

CAS: 922139-31-9

Recilisib sodium is an experimental drug that is being studied for its potential use in …

• Formel: C₁₆H₁₂ClNaO₄S
• Reinheit: Min. 95%
• Molekulargewicht: 358.8 g/mol